Diseases, Conditions, Syndromes

Mechanisms of kidney protection by gliflozins

SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli. The discovery of kidney benefits ...

Diseases, Conditions, Syndromes

Study proves safety of hypertension drugs in COVID-19 era

Patients with high blood pressure have worse COVID-19 outcomes, and this led to speculation that some anti-hypertensive medications may pose increased risks to patients dealing with hypertension.

Diseases, Conditions, Syndromes

How comorbidities increase risks for COVID patients

Comorbidities such as heart disease, respiratory disease, renal disease and cancer lead to an increased risk of death from COVID-19 according to new research from the University of East Anglia (UEA) and the Norfolk and Norwich ...

Diseases, Conditions, Syndromes

Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk

While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives—and whether they posed increased ...

Diseases, Conditions, Syndromes

Research produces different results from key China COVID-19 study

Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger ...

page 1 from 6